stockrowANI Pharmaceuticals, Inc. (ANIP) vs Cronos Group Inc. (CRON)
- ANI Pharmaceuticals, Inc. ANIP 69.03 −3.66%
- Cronos Group Inc. CRON 3.72 +5.98%
ANI Pharmaceuticals, Inc. and Cronos Group Inc. are both Drug Manufacturers Specialty & Generic companies. ANI Pharmaceuticals, Inc. is the larger, with a market value of $1.6B against $1.4B — 1.2× the size. ANI Pharmaceuticals, Inc. trades at the lower P/E: 13.3× against 21.9×. Cronos Group Inc. grew revenue faster over the last twelve months: 55.8% against 25.9%. Cronos Group Inc. has the higher net margin (28.0% vs 11.2%) and the lower return on invested capital (1.28% vs 46.4%). Across the 21 metrics below, ANI Pharmaceuticals, Inc. leads on 15 and Cronos Group Inc. on 6.
Valuation
Profitability
| Metric | ANIP | CRON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 61.06% | 46.59% | 53.51% |
| Operating margin | 15.99% | 3.78% | 0.00% |
| Net margin | 11.22% | 28.04% | (2.45%) |
| Free cash flow margin | 19.72% | 31.71% | 0.00% |
| Return on equity | 20.45% | 5.12% | (0.80%) |
| Return on assets | 7.85% | 4.87% | (1.67%) |
| Return on invested capital | 46.43% | 1.28% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack